Huae Xu

2.5k total citations
70 papers, 2.1k citations indexed

About

Huae Xu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Huae Xu has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 25 papers in Biomedical Engineering and 17 papers in Biomaterials. Recurrent topics in Huae Xu's work include Nanoplatforms for cancer theranostics (23 papers), RNA Interference and Gene Delivery (16 papers) and Nanoparticle-Based Drug Delivery (15 papers). Huae Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (23 papers), RNA Interference and Gene Delivery (16 papers) and Nanoparticle-Based Drug Delivery (15 papers). Huae Xu collaborates with scholars based in China, United States and Malaysia. Huae Xu's co-authors include Xiaolin Li, Dan Ding, Xiaowei Lu, Donghui Zheng, Sunil Krishnan, Zhenshu Zhu, Wei‐Hao Sun, Ryan T. K. Kwok, Zhibo Hou and Chris Y. Y. Yu and has published in prestigious journals such as Advanced Materials, PLoS ONE and Biomaterials.

In The Last Decade

Huae Xu

69 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huae Xu China 27 918 623 558 345 214 70 2.1k
Meiwan Chen Macao 28 1.1k 1.2× 915 1.5× 553 1.0× 430 1.2× 228 1.1× 96 2.7k
Bertrand Liagre France 31 1.6k 1.7× 372 0.6× 503 0.9× 255 0.7× 259 1.2× 107 3.1k
Jianping Zhou China 29 907 1.0× 674 1.1× 801 1.4× 186 0.5× 116 0.5× 62 2.2k
Md. Rizwanullah India 28 742 0.8× 461 0.7× 714 1.3× 147 0.4× 172 0.8× 57 2.2k
Xiang Gao China 31 1.1k 1.2× 704 1.1× 758 1.4× 337 1.0× 149 0.7× 95 2.8k
Wei Xie China 29 1.2k 1.3× 1.1k 1.7× 399 0.7× 417 1.2× 245 1.1× 78 2.7k
Li Fan China 24 748 0.8× 463 0.7× 601 1.1× 218 0.6× 97 0.5× 57 1.8k
Qiang Fu China 29 821 0.9× 481 0.8× 777 1.4× 408 1.2× 123 0.6× 94 2.5k
Yan Ma China 23 916 1.0× 545 0.9× 507 0.9× 246 0.7× 209 1.0× 74 2.2k
David Y. Léger France 25 748 0.8× 316 0.5× 249 0.4× 212 0.6× 228 1.1× 57 1.8k

Countries citing papers authored by Huae Xu

Since Specialization
Citations

This map shows the geographic impact of Huae Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huae Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huae Xu more than expected).

Fields of papers citing papers by Huae Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huae Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huae Xu. The network helps show where Huae Xu may publish in the future.

Co-authorship network of co-authors of Huae Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Huae Xu. A scholar is included among the top collaborators of Huae Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huae Xu. Huae Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuan, Jia Wang, Huimin Gao, et al.. (2025). Immunomodulating platelet-mimicking nanoparticles for AIE-based enhanced photodynamic immunotherapy against lung cancer. Materials Today Bio. 32. 101683–101683. 1 indexed citations
2.
Zhao, Qianqian, Chunming Tang, Jie Li, et al.. (2025). Biomimetic nanocrystals co-deliver paclitaxel and small-molecule LF3 for ferroptosis-combined chemotherapy for gastric cancer. Colloids and Surfaces B Biointerfaces. 251. 114586–114586. 1 indexed citations
3.
Zhao, Qianqian, Min Gu, Ting Wu, et al.. (2024). ROS responsive hydrogel for inhibition of MUC5AC against allergic rhinitis: A new delivery strategy for Ipratropium Bromide. Colloids and Surfaces B Biointerfaces. 242. 114112–114112. 4 indexed citations
4.
Wu, Min, Jia Feng, Jie Wu, et al.. (2024). A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal cord injury therapy. Materials Today Bio. 28. 101218–101218. 7 indexed citations
5.
Wen, Yuanyuan, Hui Jiang, Xiaolin Li, et al.. (2024). Dendritic Polylysine with Paclitaxel and Triptolide Codelivery for Enhanced Cancer Ferroptosis through the Accumulation of ROS. ACS Applied Materials & Interfaces. 16(16). 20143–20156. 15 indexed citations
6.
7.
Sun, Xianbao, Hui Jiang, Dan Yan, et al.. (2024). Pyruvate Kinase M2‐Responsive Release of Paclitaxel and Indoleamine 2,3‐Dioxygenase Inhibitor for Immuno‐Chemotherapy of Nonsmall Cell Lung Cancer. Advanced Science. 12(7). e2409790–e2409790. 3 indexed citations
8.
Li, Jie, Hui Jiang, Jie Wu, et al.. (2024). Synergistic Therapy of Melanoma by Co-Delivery of Dacarbazine and Ferroptosis-Inducing Ursolic Acid Using Biomimetic Nanoparticles. ACS Omega. 9(40). 41532–41543. 6 indexed citations
9.
Ding, Yan, et al.. (2024). Causal Pathways Between Breast Cancer and Cardiovascular Disease Through Mediator Factors: A Two-Step Mendelian Randomization Analysis. International Journal of Women s Health. Volume 16. 1889–1902.
10.
Jiang, Hui, Chunming Tang, Yuanyuan Wen, et al.. (2023). Enhanced Antitumor Efficacy of Novel Biomimetic Platelet Membrane-Coated Tetrandrine Nanoparticles in Nonsmall Cell Lung Cancer. Molecular Pharmaceutics. 20(11). 5463–5475. 13 indexed citations
11.
Wang, Tingting, Hui Jiang, Yanlong Chen, et al.. (2022). Targeted regulation of tumor microenvironment through the inhibition of MDSCs by curcumin loaded self-assembled nano-filaments. Materials Today Bio. 15. 100304–100304. 21 indexed citations
12.
Zhang, Yuan, Jianwei Zhang, Xiaodi Yang, et al.. (2022). Azulene-Containing Squaraines for Photoacoustic Imaging and Photothermal Therapy. ACS Applied Materials & Interfaces. 14(17). 19192–19203. 39 indexed citations
13.
Gu, Wei, Qianqian Zhao, Hong Xiao, et al.. (2022). Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection. Advanced Functional Materials. 32(43). 43 indexed citations
14.
Zhang, Ziting, Min Wu, Nan Hu, et al.. (2022). Enhanced antitumor effect of icariin nanoparticles coated with iRGD functionalized erythrocyte membrane. European Journal of Pharmacology. 931. 175225–175225. 19 indexed citations
15.
Zhang, Ziting, Nan Hu, Xinrui Zhang, et al.. (2022). Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian Journal of Pharmaceutical Sciences. 17(5). 751–766. 115 indexed citations
16.
17.
Zhang, Miaomiao, et al.. (2021). Using Fluorescence On/Off to Trace Tandem Nanofiber Assembly/Disassembly in Living Cells. Analytical Chemistry. 93(14). 5665–5669. 19 indexed citations
18.
Wang, Jia, Wenling Zhang, Ting Wu, et al.. (2021). Photodynamic antitumor activity of aggregation-induced emission luminogens as chemosensitizers for paclitaxel by concurrent induction of apoptosis and autophagic cell death. Materials Chemistry Frontiers. 5(8). 3448–3457. 7 indexed citations
19.
Li, Xiaolin, Na Yu, Jun Li, et al.. (2020). Novel “Carrier-Free” Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis. ACS Applied Materials & Interfaces. 12(9). 10096–10106. 51 indexed citations
20.
Yu, Na, Jun Li, Yuan Zhang, et al.. (2020). Superior antitumor effect of self-assembly supramolecular paclitaxel nanoparticles. RSC Advances. 10(22). 12999–13005. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meiwan Chen Breakdown of academic impact, for papers by Bertrand Liagre Breakdown of academic impact, for papers by Jianping Zhou Breakdown of academic impact, for papers by Md. Rizwanullah Breakdown of academic impact, for papers by Xiang Gao Breakdown of academic impact, for papers by Wei Xie Breakdown of academic impact, for papers by Li Fan Breakdown of academic impact, for papers by Qiang Fu Breakdown of academic impact, for papers by Yan Ma Breakdown of academic impact, for papers by David Y. Léger
Rankless by CCL
2026